Insulin aspart biosimilar（Jiangsu HengRui）
门冬胰岛素生物类似药（江苏恒瑞）
Report date: 2025/03/07 17:33:38
Base Information
Drug NameInsulin aspart biosimilar（Jiangsu HengRui）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A